Applied Materials Inc (AP2)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 340.80 |
|---|---|
| 52-week range | 174.44 – 645.40 |
| Return, 1 month / 3 months | −17.6% / −31.3% |
| Return, 1 year / 3 years | +74.2% / +176.1% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 57.0% |
| Worst drawdown (1 year) | -46.8% |
| Average daily value traded | 1.14M EUR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Applied Materials is a semiconductor equipment company based in California. It builds the machines chipmakers use to deposit, pattern and remove thin layers of material on silicon wafers, along with systems for inspecting and measuring wafers during production. It also supplies equipment for making flat panel displays and provides services and spare parts that keep installed tools running. Its customers are chip manufacturers and display makers around the world.
Applied Materials Inc trades under the code AP2 on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Applied Materials Inc (AP2) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 340.80 on 23 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 456 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 74.2% and over the last three months it fell 31.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.8% | ||
| From 52-week high | -46.8% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -31.3% | ||
| 6-month return | -2.3% | ||
| 12-month return, skipping the last month | 111.4% | ||
| Stability (higher is calmer) | 20 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.8% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 1.14M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −8.3% |
|---|---|
| 1 month | −17.6% |
| 3 months | −31.3% |
| 6 months | −2.3% |
| 1 year | +74.2% |
| 3 years | +176.1% |
| 5 years | +200.8% |
Signals
| 50-day / 200-day average | 408.26 / 386.20 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17.18 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | USD 0.4714 |
| 21 May 2026 | USD 0.4714 |
| 19 Feb 2026 | USD 0.4092 |
| 20 Nov 2025 | USD 0.4092 |
| 21 Aug 2025 | USD 0.4092 |
| 22 May 2025 | USD 0.4092 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.